Intuitive Surgical, Inc. (NASDAQ:ISRG) Given Consensus Recommendation of “Buy” by Brokerages

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) have received an average rating of “Buy” from the eighteen ratings firms that are presently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and twelve have given a buy recommendation to the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $594.15.

Several research firms recently commented on ISRG. BidaskClub lowered Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a report on Wednesday, December 11th. ValuEngine raised Intuitive Surgical from a “strong sell” rating to a “sell” rating in a report on Tuesday, December 3rd. Oppenheimer began coverage on Intuitive Surgical in a report on Wednesday, November 20th. They issued a “market perform” rating on the stock. Raymond James increased their target price on Intuitive Surgical from $610.00 to $625.00 and gave the company a “buy” rating in a report on Friday, October 18th. Finally, Zacks Investment Research raised Intuitive Surgical from a “hold” rating to a “buy” rating and set a $601.00 target price on the stock in a report on Thursday, November 21st.

NASDAQ:ISRG opened at $581.78 on Friday. The firm has a market capitalization of $67.36 billion, a PE ratio of 61.30, a price-to-earnings-growth ratio of 4.38 and a beta of 1.12. The business’s fifty day moving average price is $586.95 and its 200 day moving average price is $542.42. Intuitive Surgical has a 12 month low of $455.15 and a 12 month high of $601.60.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $3.43 EPS for the quarter, beating the consensus estimate of $2.99 by $0.44. The firm had revenue of $1.13 billion for the quarter, compared to analyst estimates of $1.06 billion. Intuitive Surgical had a return on equity of 18.26% and a net margin of 30.94%. Intuitive Surgical’s revenue for the quarter was up 22.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.83 earnings per share. On average, equities research analysts anticipate that Intuitive Surgical will post 10.98 EPS for the current fiscal year.

In other news, Director Lonnie M. Smith sold 205 shares of Intuitive Surgical stock in a transaction on Friday, November 8th. The shares were sold at an average price of $554.49, for a total value of $113,670.45. Following the transaction, the director now directly owns 368,952 shares of the company’s stock, valued at approximately $204,580,194.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Jamie Samath sold 1,021 shares of Intuitive Surgical stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $557.15, for a total transaction of $568,850.15. Following the completion of the transaction, the senior vice president now directly owns 446 shares in the company, valued at $248,488.90. The disclosure for this sale can be found here. In the last quarter, insiders sold 25,319 shares of company stock valued at $14,351,365. 1.70% of the stock is owned by company insiders.

Institutional investors have recently made changes to their positions in the company. Golden State Wealth Management LLC acquired a new position in shares of Intuitive Surgical in the 3rd quarter valued at $35,000. Nelson Van Denburg & Campbell Wealth Management Group LLC increased its holdings in shares of Intuitive Surgical by 733.3% in the 2nd quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 75 shares of the medical equipment provider’s stock valued at $39,000 after acquiring an additional 66 shares during the period. Evoke Wealth LLC acquired a new position in shares of Intuitive Surgical in the 3rd quarter valued at $43,000. North Star Investment Management Corp. acquired a new position in shares of Intuitive Surgical in the 3rd quarter valued at $49,000. Finally, Gradient Investments LLC increased its holdings in shares of Intuitive Surgical by 421.1% in the 3rd quarter. Gradient Investments LLC now owns 99 shares of the medical equipment provider’s stock valued at $53,000 after acquiring an additional 80 shares during the period. 85.58% of the stock is currently owned by institutional investors and hedge funds.

About Intuitive Surgical

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

Featured Article: Why are analyst ratings important in trading stocks?

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.